Sm. Rawls et Jf. Mcginty, MUSCARINIC RECEPTORS REGULATE EXTRACELLULAR GLUTAMATE LEVELS IN THE RAT STRIATUM - AN IN-VIVO MICRODIALYSIS STUDY, The Journal of pharmacology and experimental therapeutics, 286(1), 1998, pp. 91-98
Regulation of extracellular glutamate levels by muscarinic receptors i
n the striatum of unanesthetized rats was investigated by microdialysi
s. Extracellular glutamate levels were elevated by intrastriatal perfu
sion of L-trans-pyrrolidine-2,4-dicarboxylic acid (L-trans-PDC), a com
petitive substrate of plasma membrane excitatory amino acid transporte
rs. The nonselective muscarinic agonist, oxotremorine (0.5-54 mu M) si
gnificantly decreased L-trans-PDC-evoked glutamate levels in a concent
ration-dependent manner. Scopolamine (0.1-10 mu M), a nonselective mus
carinic receptor antagonist, reversed the effect of oxotremorine, whic
h confirms that muscarinic receptor activation mediated the reduction
of L-trans-PDC-evoked glutamate levels. In addition, scopolamine (10 m
u M) significantly elevated basal extracellular glutamate levels, an e
ffect prevented by oxotremorine, which suggests that acetylcholine ton
ically regulates glutamatergic transmission in the striatum. Previous
data from this laboratory have shown that L-trans-PDC-evoked glutamate
levels are partially calcium-dependent. The present study demonstrate
d that attenuation of L-trans-PDC-evoked glutamate levels by reduced c
alcium was not altered by oxotremorine. Therefore, it is likely that m
uscarinic receptors regulate calcium-dependent glutamate release evoke
d by L-trans-PDC.